Selective lymph node dissection in early-stage non-small cell lung cancer
- PMID: 28840011
- PMCID: PMC5542950
- DOI: 10.21037/jtd.2017.06.04
Selective lymph node dissection in early-stage non-small cell lung cancer
Abstract
Lymph node dissection is a vital part of surgical treatment in early-stage non-small cell lung cancer (NSCLC). Removal of metastatic lymph nodes while preservation of intact lymph nodes are equally important. For hospitalized early-stage patients with limited lymph node metastasis, the operation treatment should be made according to some rules such as lobe-specific lymph node drainage pattern. In order to prevent unnecessary surgical trauma in early-stage patients, a minimally invasive approach with selective lymph node excision is preferred for more clinical benefits. This review summarizes the existing findings on lobe-specific lymph node drainage pattern and we hope to provide guidance for selective lymph node dissection (SLND). Furthermore, we include information on histologic views, a tumor marker and protocols of SLND, with hope to inspire creative research and clinical trials in this field.
Keywords: Non-small cell lung cancer (NSCLC); lymph node dissection; minimally invasive surgery.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
References
-
- Howington JA, Blum MG, Chang AC, et al. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e278S-313S. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources